Youngjoo Lee

19PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 24, 2026
AdvanTIG-105: a phase I/Ib dose-expansion study of ociperlimab plus tislelizumab with or without chemotherapy in metastatic non-small cell lung cancer and extensive-stage small cell lung cancer.

|Aug 31, 2026
Central Nervous System Activity of Lazertinib in EGFR-Mutated NSCLC With Prior EGFR TKI Exposure: A Pooled Analysis of KCSG-LU20-15 and LU21-01.

|Dec 01, 2025
Fibroblast TGF-β signaling defines spatial tumor ecosystems linked to immune checkpoint blockade resistance.

Seo-Young Lee, Youngjoo Lee

|Jun 28, 2024
Seasonal influences on the efficacy of anti-programmed cell death (ligand) 1 inhibitors in lung cancer.

Hyunsoon Cho, Hoejun Kwon, Se Hyun Kim

|Jun 27, 2024
Blood Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Promising Screening Biomarkers for Brain Metastases in Patients with Lung Cancer.

Su-Hyun Kim, Beung-Chul Ahn, Dong-Eun Lee

|Jun 03, 2024
Phase II Efficacy and Safety of 80 mg Osimertinib in Patients With Leptomeningeal Metastases Associated With Epidermal Growth Factor Receptor Mutation-Positive Non-Small Cell Lung Cancer (BLOSSOM).

Sehhoon Park, Richard Baldry, Hyun Ae Jung

Pageof 4

Frequent Collaborators

4 joint publications

Beung-Chul Ahn

3 joint publications

Myung-Ju Ahn

3 joint publications

Jin-Ho Choi

2 joint publications

Min Hee Hong